GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioNxt Solutions Inc (XCNQ:BNXT) » Definitions » Scaled Net Operating Assets

BioNxt Solutions (XCNQ:BNXT) Scaled Net Operating Assets : -0.86 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioNxt Solutions Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BioNxt Solutions's operating assets for the quarter that ended in Mar. 2024 was C$0.71 Mil. BioNxt Solutions's operating liabilities for the quarter that ended in Mar. 2024 was C$1.80 Mil. BioNxt Solutions's Total Assets for the quarter that ended in Dec. 2023 was C$1.27 Mil. Therefore, BioNxt Solutions's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was -0.86.


BioNxt Solutions Scaled Net Operating Assets Historical Data

The historical data trend for BioNxt Solutions's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNxt Solutions Scaled Net Operating Assets Chart

BioNxt Solutions Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.83 0.55 0.70 0.01 -0.47

BioNxt Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.23 0.08 -0.40 -0.86

Competitive Comparison of BioNxt Solutions's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNxt Solutions's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where BioNxt Solutions's Scaled Net Operating Assets falls into.



BioNxt Solutions Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BioNxt Solutions's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(0.904-1.656)/1.613
=-0.47

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1.268 - 0.364
=0.904

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6.55 - 0 - 4.894
=1.656

BioNxt Solutions's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(0.706-1.8)/1.268
=-0.86

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.789 - 0.083
=0.706

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6.918 - 0 - 5.118
=1.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNxt Solutions Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of BioNxt Solutions's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNxt Solutions (XCNQ:BNXT) Business Description

Traded in Other Exchanges
Address
1820 Fir Street, Suite 270, Vancouver, BC, CAN, V6J 3B1
BioNxt Solutions Inc is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care Diagnostics, and Psychedelics.

BioNxt Solutions (XCNQ:BNXT) Headlines

No Headlines